_id
6919e4ad3c536f8df23180b7
Ticker
AVCT.LSE
Name
Avacta Group PLC
Exchange
LSE
Address
Scale Space White City Imperial College Campus, London, United Kingdom, W12 7RZ
Country
UK
Sector
Healthcare
Industry
Biotechnology
Currency
GBX
Website
https://avacta.com
Description
Avacta Group Plc, together with its subsidiaries, engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally. Its lead product candidate is AVA6000, a peptide drug conjugate form of doxorubicin, which is an approved cancer drug with known severe toxicities. The company is developing AVA6103, a peptide drug conjugate technology designed to deliver exatecan, a potent topoisomerase I inhibitor directly to tumors while limiting the exposure of the released exatecan in normal tissues; and AVA7100 that drives localization to fibroblast activation protein expressing tumors. The company was incorporated in 2003 and is headquartered in London, the United Kingdom.
Last Close
550000
Volume
3096651
Current Price
61.551
Change
4.459818181818181
Last Updated
2025-12-29T15:01:14.549Z
Image
https://logo.clearbit.com/avacta.com
Ipo Date
-
Market Cap
227673280
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
3.67
Strong Buy
0
Buy
2
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
56000
Cost Of Revenue
738000
Gross Profit
-682000
Operating Expenses
12410000
Operating Income
-13092000
Interest Expense
3918000
Pretax Income
-16872000
Net Income
-17023000
Eps
-0.044651241592783414
Dividends Per Share
-
Shares Outstanding
433663375
Income Tax Expense
738000
EBITDA
-12027000
Operating Margin
-23378.571428571428
Total Other Income Expense Net
-3780000
Cash
12645000
Short Term Investments
-
Receivables
3006000
Inventories
0
Total Current Assets
21991000
Property Plant Equipment
2100000
Total Assets
29237000
Payables
6600000
Short Term Debt
19416000
Long Term Debt
-
Total Liabilities
29093000
Equity
144000
Bs_currency_symbol
GBP
Depreciation
738000
Change In Working Capital
-404000
Cash From Operations
-13508000
Capital Expenditures
43000
Cash From Investing
8773000
Cash From Financing
666000
Net Change In Cash
-19886999
Cf_currency_symbol
-
PE
-
PB
162957.810420125
ROE
-11821.527777777777
ROA
-58.2241680062934
FCF
-13551000
Fcf Percent
-241.98214285714286
Piotroski FScore
1
Health Score
9
Deep Value Investing Score
1.5
Defensive Investing Score
5
Dividend Investing Score
1
Economic Moat Investing Score
3.8
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
3.5
Net Net Investing Score
1
Quality Investing Score
1
Value Investing Score
1.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
56000
Quarters > 0 > income Statement > cost Of Revenue
738000
Quarters > 0 > income Statement > gross Profit
-682000
Quarters > 0 > income Statement > operating Expenses
12410000
Quarters > 0 > income Statement > operating Income
-13092000
Quarters > 0 > income Statement > interest Expense
3918000
Quarters > 0 > income Statement > pretax Income
-16872000
Quarters > 0 > income Statement > net Income
-17023000
Quarters > 0 > income Statement > eps
-0.044651241592783414
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
381243598
Quarters > 0 > income Statement > income Tax Expense
738000
Quarters > 0 > income Statement > EBITDA
-12027000
Quarters > 0 > income Statement > operating Margin
-23378.571428571428
Quarters > 0 > income Statement > total Other Income Expense Net
-3780000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
12645000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
3006000
Quarters > 0 > balance Sheet > inventories
0
Quarters > 0 > balance Sheet > total Current Assets
21991000
Quarters > 0 > balance Sheet > property Plant Equipment
2100000
Quarters > 0 > balance Sheet > total Assets
29237000
Quarters > 0 > balance Sheet > payables
6600000
Quarters > 0 > balance Sheet > short Term Debt
19416000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
29093000
Quarters > 0 > balance Sheet > equity
144000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-17728000
Quarters > 0 > cash Flow > depreciation
738000
Quarters > 0 > cash Flow > change In Working Capital
-404000
Quarters > 0 > cash Flow > cash From Operations
-13508000
Quarters > 0 > cash Flow > capital Expenditures
43000
Quarters > 0 > cash Flow > cash From Investing
8773000
Quarters > 0 > cash Flow > cash From Financing
666000
Quarters > 0 > cash Flow > net Change In Cash
-19886999
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.044651241592783414
Quarters > 0 > ratios > PB
162957.810420125
Quarters > 0 > ratios > ROE
-11821.527777777777
Quarters > 0 > ratios > ROA
-58.2241680062934
Quarters > 0 > ratios > FCF
-13551000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-241.98214285714286
Quarters > 0 > health Score
9
Quarters > 1 > quarter
2024-06-30
Quarters > 1 > income Statement > revenue
11261000
Quarters > 1 > income Statement > cost Of Revenue
8208000
Quarters > 1 > income Statement > gross Profit
3053000
Quarters > 1 > income Statement > operating Expenses
18390000
Quarters > 1 > income Statement > operating Income
-15337000
Quarters > 1 > income Statement > interest Expense
6558000
Quarters > 1 > income Statement > pretax Income
-13032000
Quarters > 1 > income Statement > net Income
-12472000
Quarters > 1 > income Statement > eps
-0.03815226605479063
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
326900635
Quarters > 1 > income Statement > income Tax Expense
-964000
Quarters > 1 > income Statement > EBITDA
-4506000
Quarters > 1 > income Statement > operating Margin
-136.19571974069797
Quarters > 1 > income Statement > total Other Income Expense Net
1901000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
32532000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
10306000
Quarters > 1 > balance Sheet > inventories
2612000
Quarters > 1 > balance Sheet > total Current Assets
45450000
Quarters > 1 > balance Sheet > property Plant Equipment
9685000
Quarters > 1 > balance Sheet > total Assets
89294000
Quarters > 1 > balance Sheet > payables
10132000
Quarters > 1 > balance Sheet > short Term Debt
25135000
Quarters > 1 > balance Sheet > long Term Debt
166000
Quarters > 1 > balance Sheet > total Liabilities
41132000
Quarters > 1 > balance Sheet > equity
48162000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-12472000
Quarters > 1 > cash Flow > depreciation
1968000
Quarters > 1 > cash Flow > change In Working Capital
-772000
Quarters > 1 > cash Flow > cash From Operations
-12322000
Quarters > 1 > cash Flow > capital Expenditures
702000
Quarters > 1 > cash Flow > cash From Investing
-795000
Quarters > 1 > cash Flow > cash From Financing
29092000
Quarters > 1 > cash Flow > net Change In Cash
15905000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.03815226605479063
Quarters > 1 > ratios > PB
417.7787671792077
Quarters > 1 > ratios > ROE
-25.895934554212864
Quarters > 1 > ratios > ROA
-13.96734383049253
Quarters > 1 > ratios > FCF
-13024000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1.1565580321463458
Quarters > 1 > health Score
23
Quarters > 2 > quarter
2023-12-31
Quarters > 2 > income Statement > revenue
11358000
Quarters > 2 > income Statement > cost Of Revenue
6862000
Quarters > 2 > income Statement > gross Profit
4496000
Quarters > 2 > income Statement > operating Expenses
20975000
Quarters > 2 > income Statement > operating Income
-15544000
Quarters > 2 > income Statement > interest Expense
8183000
Quarters > 2 > income Statement > pretax Income
-14516000
Quarters > 2 > income Statement > net Income
-13415000
Quarters > 2 > income Statement > eps
-0.048568586369097166
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
276207339
Quarters > 2 > income Statement > income Tax Expense
1101000
Quarters > 2 > income Statement > EBITDA
-10568000
Quarters > 2 > income Statement > operating Margin
-136.8550801197394
Quarters > 2 > income Statement > total Other Income Expense Net
1028000
Quarters > 2 > income Statement > currency_symbol
GBP
Quarters > 2 > balance Sheet > cash
16627000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
4493000
Quarters > 2 > balance Sheet > inventories
2585000
Quarters > 2 > balance Sheet > total Current Assets
28036000
Quarters > 2 > balance Sheet > property Plant Equipment
9986000
Quarters > 2 > balance Sheet > total Assets
73191000
Quarters > 2 > balance Sheet > payables
3730000
Quarters > 2 > balance Sheet > short Term Debt
17559000
Quarters > 2 > balance Sheet > long Term Debt
219000
Quarters > 2 > balance Sheet > total Liabilities
51386000
Quarters > 2 > balance Sheet > equity
16903000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-13415000
Quarters > 2 > cash Flow > depreciation
1958000
Quarters > 2 > cash Flow > change In Working Capital
1506000
Quarters > 2 > cash Flow > cash From Operations
-6823000
Quarters > 2 > cash Flow > capital Expenditures
718000
Quarters > 2 > cash Flow > cash From Investing
-1650000
Quarters > 2 > cash Flow > cash From Financing
-737000
Quarters > 2 > cash Flow > net Change In Cash
-9341000
Quarters > 2 > cash Flow > currency_symbol
GBP
Quarters > 2 > ratios > PE
-0.048568586369097166
Quarters > 2 > ratios > PB
1005.7881987096374
Quarters > 2 > ratios > ROE
-79.36460983257409
Quarters > 2 > ratios > ROA
-18.32875626784714
Quarters > 2 > ratios > FCF
-7541000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.6639373129072019
Quarters > 2 > health Score
9
Quarters > 3 > quarter
2023-06-30
Quarters > 3 > income Statement > revenue
11889000
Quarters > 3 > income Statement > cost Of Revenue
6854000
Quarters > 3 > income Statement > gross Profit
5035000
Quarters > 3 > income Statement > operating Expenses
16208000
Quarters > 3 > income Statement > operating Income
-11173000
Quarters > 3 > income Statement > interest Expense
7115000
Quarters > 3 > income Statement > pretax Income
-12377000
Quarters > 3 > income Statement > net Income
-11532000
Quarters > 3 > income Statement > eps
-0.04284446355181695
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
269159631
Quarters > 3 > income Statement > income Tax Expense
-1269000
Quarters > 3 > income Statement > EBITDA
-3549000
Quarters > 3 > income Statement > operating Margin
-93.97762637732357
Quarters > 3 > income Statement > total Other Income Expense Net
-1204000
Quarters > 3 > income Statement > currency_symbol
GBP
Quarters > 3 > balance Sheet > cash
25968000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
11745000
Quarters > 3 > balance Sheet > inventories
3052000
Quarters > 3 > balance Sheet > total Current Assets
40765000
Quarters > 3 > balance Sheet > property Plant Equipment
8989000
Quarters > 3 > balance Sheet > total Assets
87748000
Quarters > 3 > balance Sheet > payables
10805000
Quarters > 3 > balance Sheet > short Term Debt
17412000
Quarters > 3 > balance Sheet > long Term Debt
238000
Quarters > 3 > balance Sheet > total Liabilities
65010000
Quarters > 3 > balance Sheet > equity
22738000
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
-11532000
Quarters > 3 > cash Flow > depreciation
1713000
Quarters > 3 > cash Flow > change In Working Capital
-770000
Quarters > 3 > cash Flow > cash From Operations
-8049000
Quarters > 3 > cash Flow > capital Expenditures
455000
Quarters > 3 > cash Flow > cash From Investing
-7351000
Quarters > 3 > cash Flow > cash From Financing
-561000
Quarters > 3 > cash Flow > net Change In Cash
-15813000
Quarters > 3 > cash Flow > currency_symbol
GBP
Quarters > 3 > ratios > PE
-0.04284446355181695
Quarters > 3 > ratios > PB
728.6060536406457
Quarters > 3 > ratios > ROE
-50.7168616413053
Quarters > 3 > ratios > ROA
-13.142179878743676
Quarters > 3 > ratios > FCF
-8504000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.7152830347379932
Quarters > 3 > health Score
13
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
113000
Annuals > 0 > income Statement > cost Of Revenue
1505000
Annuals > 0 > income Statement > gross Profit
113000
Annuals > 0 > income Statement > operating Expenses
32671000
Annuals > 0 > income Statement > operating Income
-32558000
Annuals > 0 > income Statement > interest Expense
10091000
Annuals > 0 > income Statement > pretax Income
-28983000
Annuals > 0 > income Statement > net Income
-52841000
Annuals > 0 > income Statement > eps
-0.16164239020214813
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
326900635
Annuals > 0 > income Statement > income Tax Expense
444000
Annuals > 0 > income Statement > EBITDA
-17624000
Annuals > 0 > income Statement > operating Margin
-28812.389380530978
Annuals > 0 > income Statement > total Other Income Expense Net
3575000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
12873000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
3375000
Annuals > 0 > balance Sheet > inventories
0
Annuals > 0 > balance Sheet > total Current Assets
40196000
Annuals > 0 > balance Sheet > property Plant Equipment
2785000
Annuals > 0 > balance Sheet > total Assets
48270000
Annuals > 0 > balance Sheet > payables
2796000
Annuals > 0 > balance Sheet > short Term Debt
21453000
Annuals > 0 > balance Sheet > long Term Debt
0
Annuals > 0 > balance Sheet > total Liabilities
38989000
Annuals > 0 > balance Sheet > equity
9281000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-29427000
Annuals > 0 > cash Flow > depreciation
1444000
Annuals > 0 > cash Flow > change In Working Capital
313000
Annuals > 0 > cash Flow > cash From Operations
-23597000
Annuals > 0 > cash Flow > capital Expenditures
339000
Annuals > 0 > cash Flow > cash From Investing
-1431000
Annuals > 0 > cash Flow > cash From Financing
26095000
Annuals > 0 > cash Flow > net Change In Cash
1151000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.16164239020214813
Annuals > 0 > ratios > PB
1937.2411297274
Annuals > 0 > ratios > ROE
-569.3459756491757
Annuals > 0 > ratios > ROA
-109.46964988605758
Annuals > 0 > ratios > FCF
-23936000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-211.8230088495575
Annuals > 0 > health Score
8
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2851000
Annuals > 1 > income Statement > cost Of Revenue
15000
Annuals > 1 > income Statement > gross Profit
2836000
Annuals > 1 > income Statement > operating Expenses
25968000
Annuals > 1 > income Statement > operating Income
-22005000
Annuals > 1 > income Statement > interest Expense
15298000
Annuals > 1 > income Statement > pretax Income
-31125000
Annuals > 1 > income Statement > net Income
-24947000
Annuals > 1 > income Statement > eps
-0.09148702203215571
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
272683485
Annuals > 1 > income Statement > income Tax Expense
-2370000
Annuals > 1 > income Statement > EBITDA
-14117000
Annuals > 1 > income Statement > operating Margin
-771.8344440547177
Annuals > 1 > income Statement > total Other Income Expense Net
-9120000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
16627000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
4493000
Annuals > 1 > balance Sheet > inventories
2585000
Annuals > 1 > balance Sheet > total Current Assets
28036000
Annuals > 1 > balance Sheet > property Plant Equipment
9986000
Annuals > 1 > balance Sheet > total Assets
73191000
Annuals > 1 > balance Sheet > payables
3730000
Annuals > 1 > balance Sheet > short Term Debt
17559000
Annuals > 1 > balance Sheet > long Term Debt
219000
Annuals > 1 > balance Sheet > total Liabilities
51386000
Annuals > 1 > balance Sheet > equity
21805000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-24947000
Annuals > 1 > cash Flow > depreciation
3671000
Annuals > 1 > cash Flow > change In Working Capital
736000
Annuals > 1 > cash Flow > cash From Operations
-14872000
Annuals > 1 > cash Flow > capital Expenditures
1262000
Annuals > 1 > cash Flow > cash From Investing
-9001000
Annuals > 1 > cash Flow > cash From Financing
-1298000
Annuals > 1 > cash Flow > net Change In Cash
-25154000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.09148702203215571
Annuals > 1 > ratios > PB
687.8051673927998
Annuals > 1 > ratios > ROE
-114.40953909653749
Annuals > 1 > ratios > ROA
-34.084791845991994
Annuals > 1 > ratios > FCF
-16134000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-5.65906699403718
Annuals > 1 > health Score
12
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
9653000
Annuals > 2 > income Statement > cost Of Revenue
5422000
Annuals > 2 > income Statement > gross Profit
4231000
Annuals > 2 > income Statement > operating Expenses
39888000
Annuals > 2 > income Statement > operating Income
-25493000
Annuals > 2 > income Statement > interest Expense
2701000
Annuals > 2 > income Statement > pretax Income
-41642000
Annuals > 2 > income Statement > net Income
-36940000
Annuals > 2 > income Statement > eps
-0.1446533857002085
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
255369066
Annuals > 2 > income Statement > income Tax Expense
-4659000
Annuals > 2 > income Statement > EBITDA
-34778000
Annuals > 2 > income Statement > operating Margin
-264.0940640215477
Annuals > 2 > income Statement > total Other Income Expense Net
-16149000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
41781000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
3722000
Annuals > 2 > balance Sheet > inventories
1681000
Annuals > 2 > balance Sheet > total Current Assets
55551000
Annuals > 2 > balance Sheet > property Plant Equipment
7798000
Annuals > 2 > balance Sheet > total Assets
92649000
Annuals > 2 > balance Sheet > payables
2487000
Annuals > 2 > balance Sheet > short Term Debt
59190000
Annuals > 2 > balance Sheet > long Term Debt
0
Annuals > 2 > balance Sheet > total Liabilities
74211000
Annuals > 2 > balance Sheet > equity
18438000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-39540000
Annuals > 2 > cash Flow > depreciation
3012000
Annuals > 2 > cash Flow > change In Working Capital
3873000
Annuals > 2 > cash Flow > cash From Operations
-16432000
Annuals > 2 > cash Flow > capital Expenditures
594000
Annuals > 2 > cash Flow > cash From Investing
-25042000
Annuals > 2 > cash Flow > cash From Financing
56904000
Annuals > 2 > cash Flow > net Change In Cash
15590000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.1446533857002085
Annuals > 2 > ratios > PB
761.758250894891
Annuals > 2 > ratios > ROE
-200.34710923093613
Annuals > 2 > ratios > ROA
-39.87091064123736
Annuals > 2 > ratios > FCF
-17026000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.7638039987568632
Annuals > 2 > health Score
8
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
2941000
Annuals > 3 > income Statement > cost Of Revenue
5443000
Annuals > 3 > income Statement > gross Profit
-2502000
Annuals > 3 > income Statement > operating Expenses
26552000
Annuals > 3 > income Statement > operating Income
-29054000
Annuals > 3 > income Statement > interest Expense
128000
Annuals > 3 > income Statement > pretax Income
-29194000
Annuals > 3 > income Statement > net Income
-26316000
Annuals > 3 > income Statement > eps
-0.10544947592680347
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
249560273
Annuals > 3 > income Statement > income Tax Expense
-2820000
Annuals > 3 > income Statement > EBITDA
-26690000
Annuals > 3 > income Statement > operating Margin
-987.895273716423
Annuals > 3 > income Statement > total Other Income Expense Net
-111000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
26191000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
4609000
Annuals > 3 > balance Sheet > inventories
189000
Annuals > 3 > balance Sheet > total Current Assets
34736000
Annuals > 3 > balance Sheet > property Plant Equipment
4341000
Annuals > 3 > balance Sheet > total Assets
47002000
Annuals > 3 > balance Sheet > payables
561000
Annuals > 3 > balance Sheet > short Term Debt
582000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
5780000
Annuals > 3 > balance Sheet > equity
41222000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-26374000
Annuals > 3 > cash Flow > depreciation
2376000
Annuals > 3 > cash Flow > change In Working Capital
-1130000
Annuals > 3 > cash Flow > cash From Operations
-20506000
Annuals > 3 > cash Flow > capital Expenditures
1314000
Annuals > 3 > cash Flow > cash From Investing
18703000
Annuals > 3 > cash Flow > cash From Financing
232000
Annuals > 3 > cash Flow > net Change In Cash
-1703000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.10544947592680347
Annuals > 3 > ratios > PB
332.9730487361118
Annuals > 3 > ratios > ROE
-63.83969724904177
Annuals > 3 > ratios > ROA
-55.98910684651717
Annuals > 3 > ratios > FCF
-21820000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-7.419245154709283
Annuals > 3 > health Score
26
Valuation > metrics > PE
-0.044651241592783414
Valuation > metrics > PB
162957.810420125
Valuation > final Score
20
Valuation > verdict
5431827.0% Overvalued
Profitability > metrics > ROE
-11821.527777777777
Profitability > metrics > ROA
-77.40894002091765
Profitability > metrics > Net Margin
-303.98214285714283
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
202.03472222222223
Risk > metrics > Interest Coverage
-3.341500765696784
Risk > final Score
-7
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.8452875153751538
Liquidity > metrics > Quick Ratio
0.8452875153751538
Liquidity > final Score
52
Liquidity > verdict
Weak
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
39
Prev Risks > 1
-2
Prev Risks > 2
12
Prev Liquidities > 0
82
Prev Liquidities > 1
83
Prev Liquidities > 2
86
Updated At
2026-01-20T23:00:00.896Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-05-25
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-09-30
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0423
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.0423
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-06-06
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
GBP
Earnings History > 2 > eps Actual
-0.04
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-06-30
Earnings History > 3 > report Date
2024-09-30
Earnings History > 3 > date
2024-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.02
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.02
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2023-03-31
Earnings History > 4 > report Date
2023-04-25
Earnings History > 4 > date
2023-03-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
-0.12
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2022-06-30
Earnings History > 5 > report Date
2022-09-30
Earnings History > 5 > date
2022-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
-0.04
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2022-03-31
Earnings History > 6 > report Date
2022-04-06
Earnings History > 6 > date
2022-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
-0.11
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2021-06-30
Earnings History > 7 > report Date
2021-09-30
Earnings History > 7 > date
2021-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
-0.04
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2021-03-31
Earnings History > 8 > report Date
2021-04-22
Earnings History > 8 > date
2021-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
GBP
Earnings History > 8 > eps Actual
-0.05
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.05
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2020-12-31
Earnings History > 9 > report Date
2021-03-29
Earnings History > 9 > date
2020-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
GBP
Earnings History > 9 > eps Actual
0
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2020-06-30
Earnings History > 10 > report Date
2020-09-28
Earnings History > 10 > date
2020-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
GBP
Earnings History > 10 > eps Actual
-0.04
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.04
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2020-03-31
Earnings History > 11 > report Date
2020-05-06
Earnings History > 11 > date
2020-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
GBP
Earnings History > 11 > eps Actual
-0.04
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.04
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2019-09-30
Earnings History > 12 > report Date
2019-10-18
Earnings History > 12 > date
2019-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
GBP
Earnings History > 12 > eps Actual
-0.04
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.04
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2019-03-31
Earnings History > 13 > report Date
2019-04-30
Earnings History > 13 > date
2019-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
GBP
Earnings History > 13 > eps Actual
-0.05
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.05
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2018-09-30
Earnings History > 14 > report Date
2018-10-02
Earnings History > 14 > date
2018-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
GBP
Earnings History > 14 > eps Actual
-0.08
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.08
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2018-03-31
Earnings History > 15 > report Date
2018-04-02
Earnings History > 15 > date
2018-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
GBP
Earnings History > 15 > eps Actual
-0.06
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.06
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-09-30
Earnings History > 16 > report Date
2017-10-04
Earnings History > 16 > date
2017-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
GBP
Earnings History > 16 > eps Actual
-0.04
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.04
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2017-03-31
Earnings History > 17 > report Date
2017-04-24
Earnings History > 17 > date
2017-03-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
GBP
Earnings History > 17 > eps Actual
-0.05
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.05
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2016-09-30
Earnings History > 18 > report Date
2016-10-17
Earnings History > 18 > date
2016-09-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
GBP
Earnings History > 18 > eps Actual
-0.04
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.04
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2016-03-31
Earnings History > 19 > report Date
2016-04-25
Earnings History > 19 > date
2016-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
GBP
Earnings History > 19 > eps Actual
-0.03
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.03
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2014-09-30
Earnings History > 20 > report Date
2014-10-23
Earnings History > 20 > date
2014-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
GBP
Earnings History > 20 > eps Actual
0
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2014-03-31
Earnings History > 21 > report Date
2014-04-23
Earnings History > 21 > date
2014-03-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
GBP
Earnings History > 21 > eps Actual
0
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2013-09-30
Earnings History > 22 > report Date
2013-10-24
Earnings History > 22 > date
2013-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
GBP
Earnings History > 22 > eps Actual
0
Earnings History > 22 > eps Estimate
-2
Earnings History > 22 > eps Difference
2
Earnings History > 22 > surprise Percent
100
Avacta Group Plc, together with its subsidiaries, engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally. Its lead product candidate is AVA6000, a peptide drug conjugate form of doxorubicin, which is an approved cancer drug with known severe toxicities. The company is developing AVA6103, a peptide drug conjugate technology designed to deliver exatecan, a potent topoisomerase I inhibitor directly to tumors while limiting the exposure of the released exatecan in normal tissues; and AVA7100 that drives localization to fibroblast activation protein expressing tumors. The company was incorporated in 2003 and is headquartered in London, the United Kingdom.
Stock Price
GBp 0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAvacta Group Plc FTSE AIM All Share Focused Update on Biotechnology Operations - Kalkine Media
1/20/2026
Avacta Group Plc FTSE AIM All Share Focused Update on Biotechnology Operations Kalkine Media
Read more →Avacta Group within FTSE AIM All-Share and UK Life Sciences Sector Kalkine Media
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
2
Hold
1
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Avacta Group PLC
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
2025-06-30
EPS Actual
-0.0423
EPS Estimate
0
EPS Difference
-0.0423
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.